Maze Therapeutics Ownership | Who Owns Maze Therapeutics?

Maze Therapeutics Ownership Summary

Maze Therapeutics is owned by 39.02% institutional investors, 11.49% insiders, and 49.49% retail investors. Trv gp iv is the largest institutional shareholder, holding 13.85% of MAZE shares.

MAZE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Maze Therapeutics	39.02%	11.49%	49.49%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Trv gp iv	6.07M	13.85%	$157.50M
Frazier life sciences management	4.57M	10.42%	$118.43M
Arch venture management	4.12M	9.40%	$106.83M
Deep track capital, lp	3.95M	9.01%	$102.40M
Alphabet	2.41M	5.50%	$62.56M
Ah capital management	1.70M	3.88%	$44.14M
Matrix capital management company, lp	1.65M	3.77%	$42.88M
Vanguard group	1.33M	3.04%	$34.62M
Blackrock funding, inc. /de	1.32M	3.00%	$34.12M
Vr adviser	1.23M	2.81%	$31.91M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Trv gp iv	6.07M	57.49%	$157.50M
Matrix capital management company, lp	1.65M	40.17%	$42.88M
Arch venture management	4.12M	21.70%	$106.83M
Foresite capital management iv	522.66K	7.42%	$13.55M
Trv gp v	950.80K	6.97%	$24.65M
Frazier life sciences management	4.57M	3.55%	$118.43M
Ah capital management	1.70M	3.16%	$44.14M
Washington university	210.68K	3.06%	$5.46M
Deep track capital, lp	3.95M	2.86%	$102.40M
Logos global management lp	1.23M	2.85%	$31.82M

Top Buyers

Holder	Shares	% Assets	Change
Vr adviser	1.23M	1.80%	1.23M
Vanguard group	1.33M	0.00%	915.34K
Marshall wace, llp	777.70K	0.02%	758.10K
Blackrock funding, inc. /de	1.32M	0.00%	701.31K
Logos global management lp	1.23M	2.85%	615.39K

Top Sellers

Holder	Shares	% Assets	Change
Foresite capital management iv	522.66K	7.42%	-1.59M
Matrix capital management company, lp	1.65M	40.17%	-832.50K
Harvard management	92.40K	0.11%	-545.13K
Foresite capital management v	86.29K	2.06%	-258.90K
Affinity asset advisors	-	-	-250.00K

New Positions

Holder	Shares	% Assets	Change	Value
Vr adviser	1.23M	1.80%	1.23M	$31.91M
Arrowmark colorado	545.13K	0.26%	545.13K	$14.14M
Washington university	210.68K	3.06%	210.68K	$5.46M
Parkman healthcare partners	200.00K	0.54%	200.00K	$5.19M
Schonfeld strategic advisors	114.05K	0.02%	114.05K	$2.96M

Sold Out

Holder	Change
Comerica bank	-636.00
Corebridge financial	-4.33K
Engineers gate manager lp	-10.21K
Davidson kempner capital management lp	-13.67K
Oxford asset management llp	-17.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	49	-33.78%	17,110,255	-55.94%	39	0.50%	34	-19.05%	7	-46.15%
Jun 30, 2025	74	15.63%	38,836,437	8.98%	88	0.57%	42	-34.38%	13	-
Mar 31, 2025	67	-	40,037,113	-	139	-	67	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 15, 2025	SCHELLER RICHARD H	-	Sell	$464.03K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	1

MAZE Ownership FAQ

Who Owns Maze Therapeutics?

Maze Therapeutics shareholders are primarily institutional investors at 39.02%, followed by 11.49% insiders and 49.49% retail investors. The average institutional ownership in Maze Therapeutics's industry, Biotech Stocks , is 45.24%, which Maze Therapeutics falls below.

Who owns the most shares of Maze Therapeutics?

Maze Therapeutics’s largest shareholders are Trv gp iv (6.07M shares, 13.85%), Frazier life sciences management (4.57M shares, 10.42%), and Arch venture management (4.12M shares, 9.40%). Together, they hold 33.66% of Maze Therapeutics’s total shares outstanding.

Does Blackrock own Maze Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Maze Therapeutics.

Who is Maze Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Maze Therapeutics’s biggest shareholder by percentage of total assets invested, with 57.49% of its assets in 6.07M Maze Therapeutics shares, valued at 157.5M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools